Endo International PLC Earns Outperform Rating from Analysts at RBC Capital (ENDP)
Analysts at RBC Capital started coverage on shares of Endo International PLC (NASDAQ:ENDP) in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $80.00 price target on the stock. RBC Capital’s price objective would indicate a potential upside of 25.57% from the company’s current price.
A number of other analysts have also recently weighed in on ENDP. Analysts at Zacks reiterated a “neutral” rating on shares of Endo International PLC in a research note on Friday, August 1st. They now have a $70.00 price target on the stock. Separately, analysts at Stifel Nicolaus raised their price target on shares of Endo International PLC from $75.00 to $84.00 in a research note on Friday, August 1st. They now have a “buy” rating on the stock. Finally, analysts at Sterne Agee raised their price target on shares of Endo International PLC from $1.00 to $75.00 in a research note on Thursday, July 31st. One investment analyst has rated the stock with a sell rating, eight have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $74.00.
Shares of Endo International PLC (NASDAQ:ENDP) traded up 0.19% during mid-day trading on Tuesday, hitting $63.83. 1,688,279 shares of the company’s stock traded hands. Endo International PLC has a 52 week low of $41.04 and a 52 week high of $82.16. The stock has a 50-day moving average of $65.38 and a 200-day moving average of $68.12. The company’s market cap is $9.796 billion.
Endo International PLC (NASDAQ:ENDP) last issued its quarterly earnings data on Thursday, July 31st. The company reported $1.06 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.88 by $0.18. The company had revenue of $719.00 million for the quarter, compared to the consensus estimate of $644.60 million. During the same quarter in the prior year, the company posted $1.42 earnings per share. The company’s quarterly revenue was up .9% on a year-over-year basis. Analysts expect that Endo International PLC will post $4.05 EPS for the current fiscal year.
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.
Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.